Drug Approvals
🇺🇸 FDA Page 34FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 397–408 of 665 articles
Bristol Myers' $1B Manufacturing Plant Plans in Houston
AI Revolutionizes Treatment for Newborn's Ultra Rare Disease
The Rise of Perimenopause Misinformation: Implications for Pharma
Senate Democrats Propose Long-Term Care Benefit for Medicare
Impact of Trump's Foreign Aid Cuts on Ebola Response
Virginia Governor Vetoes Legislation on Prescription Drug Costs
SELLAS Nears Key AML Data: Insights for Investors and BD Teams
FDA's Bayesian Methodology: A Game Changer for Drug Development
Palvella's Nasdaq Uplisting: Implications for Rare Disease Development
Britain's Tobacco Regulation: Lessons from Massachusetts
Supreme Court Setback for Pharma and TrumpRx Expansion Insights
The Financial Implications of Spine Surgery Under the No Surprises Act